[OP.4C.04] SAFETY AND PERFORMANCE OF THE ENLIGHTN RENAL DENERVATION SYSTEM IN PATIENTS WITH DRUG-RESISTANT HYPERTENSION: POOLED ANALYSES FROM THE ENLIGHTN 1, 2 AND 3 TRIALS.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27508709)

Published in J Hypertens on September 01, 2016

Authors

M D Lobo1, J Montarello, M Saxena, A Jain, D Walters, M Pincus, C Tsioufis, V Papademetriou, S Worthley

Author Affiliations

1: 1Cardiovascular Research Center, Royal Adelaide Hospital and Department of Medicine, University of Adelaide, Adelaide, AUSTRALIA 2Queen Mary University of London, William Harvey Heart Centre, NIHR Cardiovascular Biomedical Research Unit, London, UNITED KINGDOM 3Barts Hypertension Clinic, Department of Clinical Pharmacology, Barts Health NHS Trust, London, UNITED KINGDOM 4Departments of Cardiology, London Chest Hospital, Barts Health NHS Trust, London, UNITED KINGDOM 5Prince Charles Hospital, Brisbane, AUSTRALIA 6Hippokration Hospital, Athens, GREECE 7Georgetown University, Washington DC, USA.

Articles by these authors

(truncated to the top 100)

FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70

Kidney transplantation under FK 506. JAMA (1990) 7.45

Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax (1992) 6.28

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Reiter's disease and HL-A 27. Lancet (1973) 4.10

Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med (2001) 4.01

Implementation of a high-sensitivity Micro-Angiographic Fluoroscope (HS-MAF) for in-vivo endovascular image guided interventions (EIGI) and region-of-interest computed tomography (ROI-CT). Proc SPIE Int Soc Opt Eng (2008) 3.49

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA (2001) 3.12

Demographic study of a wild house sparrow population by DNA fingerprinting. Nature (1987) 3.08

Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation (1992) 2.75

Acute anterior uveitis and HL-A 27. Lancet (1973) 2.74

A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49

Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48

Maternal feeding practices and beliefs and their relationships to overweight in early childhood. J Dev Behav Pediatr (2001) 2.39

The effects of FK 506 on renal function after liver transplantation. Transplant Proc (1990) 2.31

Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc (1991) 2.26

Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clin Cancer Res (2001) 2.22

Clinical significance of histological classification of idiopathic interstitial pneumonia. Eur Respir J (2002) 2.19

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology (1999) 2.15

Cardiovascular risk assessment of South Asians in a religious setting: a feasibility study. Int J Clin Pract (2011) 2.12

One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc (1991) 2.10

Reduction in radiation exposure during coronary angiography. Cathet Cardiovasc Diagn (1990) 2.03

Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet (1995) 1.96

BCL-6 expression during B-cell activation. Blood (1996) 1.95

Voltage-dependent trans-bilayer orientation of melittin. J Biol Chem (1982) 1.86

Carotid artery disease as a marker for the presence of severe coronary artery disease in patients evaluated for chest pain. Stroke (1999) 1.84

Regulation of the cystic fibrosis transmembrane conductance regulator Cl- channel by negative charge in the R domain. J Biol Chem (1993) 1.80

Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor. J Exp Med (2001) 1.79

Severity of coronary artery disease in black and white male veterans and likelihood of revascularization. Am Heart J (2000) 1.76

Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc (1991) 1.75

Investigating the thyroid nodule. BMJ (2009) 1.73

The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. J Am Coll Surg (1996) 1.71

Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc (1991) 1.69

HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet (1974) 1.68

Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur J Immunol (1999) 1.67

Efficacy of breathing and coughing exercises in the prevention of pulmonary complications after coronary artery surgery. Chest (1994) 1.66

Homologies between members of the germin gene family in hexaploid wheat and similarities between these wheat germins and certain Physarum spherulins. J Biol Chem (1991) 1.65

The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc (1991) 1.60

Accuracy and applicability of the revised WHO classification (2009) of dengue in children seen at a tertiary healthcare facility in northern India. Infection (2013) 1.59

Oral glucose tolerance test in liver recipients treated with FK 506. Transplant Proc (1990) 1.56

Ambiguous coronary angiography: clinical utility of intravascular ultrasound. Cathet Cardiovasc Diagn (1992) 1.54

Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation (1992) 1.53

Concurrent dengue virus and Japanese encephalitis virus infection of the brain: is it co-infection or co-detection? Infection (2012) 1.52

Polymerase chain reaction vs. conventional diagnosis in fine needle aspirates of tuberculous lymph nodes. Acta Cytol (2001) 1.51

Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J (1995) 1.51

An analysis of early renal transplant protocol biopsies--the high incidence of subclinical tubulitis. Am J Transplant (2001) 1.48

Bacteriology of neonatal septicaemia in a tertiary care hospital of northern India. Indian J Med Microbiol (2007) 1.48

Converted laparoscopic colorectal surgery. Surg Endosc (2001) 1.48

Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis. Chest (1991) 1.47

Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med (1995) 1.47

Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation (1992) 1.45

Coronary artery fistula related to dilatation of totally occluded vessel. Clin Cardiol (1993) 1.44

Glutathione is required for intestinal function. Proc Natl Acad Sci U S A (1990) 1.43

Transversus abdominis plane block using the loss of resistance to air technique. Minerva Anestesiol (2012) 1.43

Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. Proc Natl Acad Sci U S A (1991) 1.43

Early changes in plasma and urinary potassium in diuretic-treated patients with systemic hypertension. Am J Cardiol (1984) 1.43

Radical radiotherapy and salvage cystectomy as the primary management of transitional cell carcinoma of the bladder. Results following the introduction of a CT planning technique. Clin Oncol (R Coll Radiol) (2002) 1.42

Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41

Treatment of new pulmonary tuberculosis patients: what do allopathic doctors do in India? Int J Tuberc Lung Dis (2002) 1.40

Mandibular nerve block for peri-operative pain relief using a peripheral nerve stimulator. Anaesthesia (2012) 1.40

Gallbladder carcinoma: experience of 116 cases. Trop Gastroenterol (2000) 1.39

Induction of ventricular tachycardia in patients with left ventricular aneurysms and no history of arrhythmia. Am J Cardiol (1988) 1.39

Vascular complications after hemostatic puncture closure device (Angio-Seal) are not higher in overweight patients. J Invasive Cardiol (2001) 1.39

Electrocardiographic abnormalities suggestive of myocardial ischemia during upper gastrointestinal bleeding. Am J Cardiol (1995) 1.39

Administration of an alginate based gastric reflux suppressant on the bioavailability of omeprazole. Indian J Med Res (2006) 1.39

Hypokalaemia mimicking Guillain-Barre syndrome. J Assoc Physicians India (1989) 1.39

Methotrexate for rheumatoid arthritis. J Assoc Physicians India (1994) 1.39

Thoracic epidural catheterization leading to delayed transient neurological symptoms with normal imaging findings. Acta Anaesthesiol Scand (2008) 1.38

Glutathione ester prevents buthionine sulfoximine-induced cataracts and lens epithelial cell damage. Proc Natl Acad Sci U S A (1989) 1.37

FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37

Neurologic complications of FK 506. Transplant Proc (1991) 1.34

Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg (1994) 1.33

Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clin Pharmacol Ther (2009) 1.32

Rapid reversible substrate regulation of fructose transporter expression in rat small intestine and kidney. Am J Physiol (1994) 1.31

Adenosine triphosphate-dependent transport of doxorubicin, daunomycin, and vinblastine in human tissues by a mechanism distinct from the P-glycoprotein. J Clin Invest (1994) 1.30

Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM. Am J Physiol (1996) 1.30

Infections with FK 506 immunosuppression: preliminary results with primary therapy. Transplant Proc (1990) 1.30

De novo malignancies after liver transplantation: a major cause of late death. Liver Transpl (2001) 1.30

Pharmacokinetics of FK 506 in transplant patients. Transplant Proc (1991) 1.30

Prevalence of dental caries and treatment needs in the school-going children of rural areas in Udaipur district. J Indian Soc Pedod Prev Dent (2007) 1.29

Coronary artery fistula: an abnormality affecting all age groups. Medicine (Baltimore) (1990) 1.27

Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. J Postgrad Med (2010) 1.27

Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant (2006) 1.26

Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clin Pharmacol Ther (2010) 1.26

Development of satranidazole mucoadhesive gel for the treatment of periodontitis. AAPS PharmSciTech (2009) 1.25

Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation (2001) 1.25

An analysis of time utilization and cancellations of scheduled cases in the main operation theater complex of a tertiary care teaching institute of North India. J Postgrad Med (2014) 1.24

An immunologically active arabinogalactan from Tinospora cordifolia. Phytochemistry (1999) 1.22

Immunopathological study of spleen during Japanese encephalitis virus infection in mice. Br J Exp Pathol (1988) 1.22

Water nitrates and CNS birth defects: a population-based case-control study. Arch Environ Health (1988) 1.22

The initiator element: a paradigm for core promoter heterogeneity within metazoan protein-coding genes. Cold Spring Harb Symp Quant Biol (1998) 1.21

Mechanism of synergy between TATA and initiator: synergistic binding of TFIID following a putative TFIIA-induced isomerization. Genes Dev (1997) 1.21

Glutathione metabolism in the lung: inhibition of its synthesis leads to lamellar body and mitochondrial defects. Proc Natl Acad Sci U S A (1989) 1.21

Prevalence of gingival diseases, malocclusion and fluorosis in school-going children of rural areas in Udaipur district. J Indian Soc Pedod Prev Dent (2007) 1.21

Inhibitory role for dual specificity phosphatase VHR in T cell antigen receptor and CD28-induced Erk and Jnk activation. J Biol Chem (2000) 1.20

Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population : the LIFE study. Hypertension (2000) 1.20

Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc (1993) 1.18